Evolving paradigms that determine the fate of an allograft: Minireview

American Journal of Transplantation

Volumn 10, Issue 5, 2010, Pages 1143-1148

  Bromberg, J S ^a,b   Heeger, P S ^a,c   Li, X C ^d  

^a Immunology Institute   (Italy)

^b Department of Gene and Cell Medicine ^*  (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Complement; Lymph node; Lymphocyte trafficking; Natural killer cells; Rejection; Tolerance

Indexed keywords

CD8 ANTIGEN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; FINGOLIMOD; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR;

ALLOIMMUNITY; ALLOTRANSPLANTATION; CELLULAR IMMUNITY; COMPLEMENT SYSTEM; DRUG RECEPTOR BINDING; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE CELL; LYMPHATIC SYSTEM; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME;

ANIMALS; CLINICAL PROTOCOLS; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; KILLER CELLS, NATURAL; T-LYMPHOCYTES;

EID: 77951243091     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03033.x     Document Type: Short Survey

References (54)

1. Medof ME, Kinoshita T, Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med 1984 160 1558 1578. (Pubitemid 15220783)
2. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999 10 : 2208 2214.
3. Farrar CA, Zhou W, Lin T, Sacks SH. Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J 2006 20 : 217 226. (Pubitemid 44933168)
4. Pratt JR, Abe K, Miyazaki M et al. In situ localization of C3 synthesis in experimental acute renal allograft rejection. Am J Pathol 2000 157 : 825 831. (Pubitemid 32109375)
5. Sacks S, Zhou W. New boundaries for complement in renal disease. J Am Soc Nephrol 2008 19 : 1865 1869.
6. Yamada K, Miwa T, Liu J et al. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 2004 172 : 3869 3875. (Pubitemid 38337974)
7. Pratt JR, Jones ME, Dong J et al. Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol 2003 163 : 1457 1465. (Pubitemid 37175093)
8. Sheerin NS, Risley P, Abe K et al. Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J 2008 22 : 1065 1072. (Pubitemid 351519961)
9. Heeger PS, Lalli PN, Lin F et al. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 2005 201 : 1523 1530. (Pubitemid 40720998)
10. Lalli PN, Strainic MG, Lin F et al. Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production. J Immunol 2007 179 : 5793 5802.
11. Lalli PN, Strainic MG, Yang M et al. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 2008 112 : 1759 1766.
12. Pavlov V, Raedler H, Yuan S et al. Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J Immunol 2008 181 : 4580 4589.
13. Strainic MG, Liu J, Huang D et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008 28 : 425 435.
14. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002 8 : 582 587.
15. Keslar K, Rodriguez ER, Tan CD et al. Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury. Transplantation 2008 86 : 1319 1321.
16. Gueler F, Rong S, Gwinner W et al. Complement 5a receptor inhibition improves renal allograft survival. J Am Soc Nephrol 2008 19 : 2302 2312.
17. Naesens M, Li L, Ying L et al. Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol 2009 20 : 1839 1851.
18. Varagunam M, Yaqoob MM, Dohler B, Opelz G. C3 polymorphisms and allograft outcome in renal transplantation. N Engl J Med 2009 360 : 874 880.
19. Hamerman JA, Ogasawara K, Lanier LL. NK cells and innate immunity. Curr Opin Immunol 2005 17 : 1 7.
20. Lanier LL. NK cell recognition. Annu Rev Immunol 2005 23 : 225 274.
21. Chan CW, Crafton E, Fan HN et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat Med 2006 12 : 207 213. (Pubitemid 43214747)
22. Vosshenrich CAJ, Lesjean-Pottier S, Hasan M et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med 2007 204 : 2569 2578. (Pubitemid 350044783)
23. Kroemer, A., Xiao X, Degauque N et al. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008 180 : 7818 7826.
24. Maier S, Tertilt C, Chambron N et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001 7 : 557 562. (Pubitemid 32448322)
25. Roy S, Barnes PF, Garg A, Wu S, Cosman D, Vankayalapati R. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol 2008 180 : 1729 1736.
26. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009 457 : 557 561.
27. Townsend MJ, Weinmann AS, Matsuda JL et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004 20 : 477 494.
28. Sun JC, Lanier LL. Tolerance of NK cells encountering their viral ligand during development. J Exp Med 2008 205 : 1819 1828.
29. Beilke JN, Kuhl NR, Kaer LV, Gill RG. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2002 11 : 1059 1065.
30. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006 203 : 1851 1858. (Pubitemid 44188459)
31. Deniz G, Erten G, Kucuksezer UC et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol 2008 180 : 850 857.
32. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005 438 : 946 953. (Pubitemid 43093960)
33. Ledgerwood LG, Lal G, Zhang N et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 2008 : 9 : 42 53. (Pubitemid 350286203)
34. Roozendaal R, Mempel TR, Pitcher LA et al. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity 2009 30 : 264 276.
35. Kataru RP, Jung K, Jang C et al. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009 113 : 5650 5659.
36. Stuht S, Gwinner W, Franz I et al. Lymphatic neoangiogenesis in human renal allografts: Results from sequential protocol biopsies. Am J Transpl 2007 7 : 377 384. (Pubitemid 46096330)
37. Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol 2006 177 : 3369 3379. (Pubitemid 44277857)
38. Webster B, Ekland EH, Agle LM et al. Regulation of lymph node vascular growth by dendritic cells. J Exp Med 2006 203 : 1903 1913. (Pubitemid 44188465)
39. Soderberg KA, Payne GW, Sato A et al. Innate control of adaptive immunity via remodeling of lymph node feed arteriole. Proc Natl Acad Sci USA 2005 : 102 : 16315 16320. (Pubitemid 41688911)
40. Chyou S, Ekland EE, Carpenter AC et al. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J Immunol 2008 181 : 3887 3896.
41. Tammela T, Zarkada G, Wallgard E et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008 454 : 656 660.
42. Ochsenbein AF, Sierro S, Odermatt B et al. Roles of tumour localization, second signals and cross priming in cytotoxic T cell induction. Nature 2001 411 : 1058 1064. (Pubitemid 32612331)
43. Lakkis FG, Arakelov A, Konieczny BT. Immunologic "ignorance" of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000 6 : 686 688. (Pubitemid 30398793)
44. Alvarez D, Swirski FK, Yang T et al. Inhalation tolerance is induced selectively in thoracic lymph nodes but executed pervasively at distant mucosal and nonmucosal tissues. J Immunol 2006 176 : 2568 2580. (Pubitemid 43201709)
45. Hintzen G, Ohl L, del Rio M et al. Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node. J Immunol 2006 177 : 7346 7354. (Pubitemid 44715105)
46. Lim HW, Hillsamer P, Kim CH. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 2004 114 : 1640 1649. (Pubitemid 40385555)
47. Chen Y, Choisy-Rossi C, Holl TM et al. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J Immunol 2005 174 : 1196 1204.
48. Lee J, Epardaud M, Sun J et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol 2007 8 : 181 190. (Pubitemid 46152649)
49. Ochando JC, Homma C, Yang Y et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006 7 : 652 662. (Pubitemid 43797347)
50. Gommerman JL, Browning JL. Lymphotoxin/LIGHT, lymphoid microenvironments and autoimmune disease. Nature 2003 3 : 642 655.
51. Browning JL, Allaire N, Ngam-ed A et al. Lymphotoxin-β receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 2005 23 : 539 550. (Pubitemid 41587893)
52. Hill JA, Feuerer M, Tash K et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007 27 : 786 800. (Pubitemid 350110546)
53. Fan K, Wang H, Wei H et al. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance. Transplantation 2007 84 : 746 754. (Pubitemid 47480660)
54. Tao R, Wang L, Murphy K et al. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells. J Immunol 2008 180 : 6649 6655.